CN106237234A - Improve Herba Taraxaci oral liquor and the oral liquid thereof of immunity - Google Patents
Improve Herba Taraxaci oral liquor and the oral liquid thereof of immunity Download PDFInfo
- Publication number
- CN106237234A CN106237234A CN201610626472.7A CN201610626472A CN106237234A CN 106237234 A CN106237234 A CN 106237234A CN 201610626472 A CN201610626472 A CN 201610626472A CN 106237234 A CN106237234 A CN 106237234A
- Authority
- CN
- China
- Prior art keywords
- parts
- component
- herba taraxaci
- herba
- immunity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 55
- 230000036039 immunity Effects 0.000 title claims abstract description 46
- 239000003814 drug Substances 0.000 claims abstract description 81
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 71
- 229940079593 drug Drugs 0.000 claims abstract description 44
- 238000000605 extraction Methods 0.000 claims abstract description 36
- 238000010438 heat treatment Methods 0.000 claims abstract description 21
- 230000008901 benefit Effects 0.000 claims abstract description 19
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 14
- 239000004375 Dextrin Substances 0.000 claims abstract description 7
- 229920001353 Dextrin Polymers 0.000 claims abstract description 7
- 235000019425 dextrin Nutrition 0.000 claims abstract description 7
- 238000004321 preservation Methods 0.000 claims abstract description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000010992 reflux Methods 0.000 claims abstract description 5
- 241000628997 Flos Species 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 19
- 239000000706 filtrate Substances 0.000 claims description 18
- 230000000844 anti-bacterial effect Effects 0.000 claims description 15
- 241000746375 Andrographis Species 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 14
- 210000000582 semen Anatomy 0.000 claims description 14
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 12
- 239000006228 supernatant Substances 0.000 claims description 12
- 238000000108 ultra-filtration Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 230000002829 reductive effect Effects 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 10
- -1 filters Substances 0.000 claims description 8
- 239000011347 resin Substances 0.000 claims description 8
- 229920005989 resin Polymers 0.000 claims description 8
- 230000006837 decompression Effects 0.000 claims description 7
- 238000005325 percolation Methods 0.000 claims description 7
- 229910000831 Steel Inorganic materials 0.000 claims description 6
- 239000010959 steel Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 5
- 239000002674 ointment Substances 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 238000010828 elution Methods 0.000 claims description 4
- 238000004064 recycling Methods 0.000 claims description 4
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 3
- 235000011613 Pinus brutia Nutrition 0.000 claims description 3
- 241000018646 Pinus brutia Species 0.000 claims description 3
- 238000007598 dipping method Methods 0.000 claims description 3
- 238000002481 ethanol extraction Methods 0.000 claims description 3
- 238000011068 loading method Methods 0.000 claims description 3
- 239000012567 medical material Substances 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 230000000274 adsorptive effect Effects 0.000 claims description 2
- 239000008367 deionised water Substances 0.000 claims description 2
- 229910021641 deionized water Inorganic materials 0.000 claims description 2
- 239000012153 distilled water Substances 0.000 claims description 2
- 210000000952 spleen Anatomy 0.000 abstract description 23
- 210000003734 kidney Anatomy 0.000 abstract description 22
- 230000007812 deficiency Effects 0.000 abstract description 10
- 235000019640 taste Nutrition 0.000 abstract description 9
- 208000009205 Tinnitus Diseases 0.000 abstract description 5
- 235000019789 appetite Nutrition 0.000 abstract description 5
- 230000036528 appetite Effects 0.000 abstract description 5
- 210000003127 knee Anatomy 0.000 abstract description 5
- 231100000886 tinnitus Toxicity 0.000 abstract description 5
- 201000001881 impotence Diseases 0.000 abstract description 4
- 208000005946 Xerostomia Diseases 0.000 abstract description 3
- 206010013781 dry mouth Diseases 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 230000003860 sleep quality Effects 0.000 abstract description 2
- 206010029446 nocturia Diseases 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 38
- 210000004369 blood Anatomy 0.000 description 37
- 210000004185 liver Anatomy 0.000 description 34
- 230000000694 effects Effects 0.000 description 31
- 235000019441 ethanol Nutrition 0.000 description 28
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- 230000001717 pathogenic effect Effects 0.000 description 18
- 206010007247 Carbuncle Diseases 0.000 description 16
- 208000002193 Pain Diseases 0.000 description 15
- 201000010099 disease Diseases 0.000 description 14
- 230000006870 function Effects 0.000 description 14
- 208000033065 inborn errors of immunity Diseases 0.000 description 14
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 206010023126 Jaundice Diseases 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 13
- 206010037660 Pyrexia Diseases 0.000 description 13
- 238000000034 method Methods 0.000 description 13
- 231100000614 poison Toxicity 0.000 description 13
- 210000002784 stomach Anatomy 0.000 description 13
- 241000699666 Mus <mouse, genus> Species 0.000 description 12
- 210000001541 thymus gland Anatomy 0.000 description 12
- 210000004209 hair Anatomy 0.000 description 11
- 238000010926 purge Methods 0.000 description 11
- 230000036541 health Effects 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- 208000004880 Polyuria Diseases 0.000 description 8
- 206010040943 Skin Ulcer Diseases 0.000 description 8
- 210000001744 T-lymphocyte Anatomy 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 201000007227 lymph node tuberculosis Diseases 0.000 description 8
- 230000027939 micturition Effects 0.000 description 8
- 244000052769 pathogen Species 0.000 description 8
- 231100000019 skin ulcer Toxicity 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 208000004396 mastitis Diseases 0.000 description 7
- 239000002574 poison Substances 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 239000003053 toxin Substances 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 210000000232 gallbladder Anatomy 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 244000000010 microbial pathogen Species 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 206010040872 skin infection Diseases 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 231100000419 toxicity Toxicity 0.000 description 6
- 230000001988 toxicity Effects 0.000 description 6
- 231100000765 toxin Toxicity 0.000 description 6
- 241000700199 Cavia porcellus Species 0.000 description 5
- 206010010726 Conjunctival oedema Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 210000000987 immune system Anatomy 0.000 description 5
- 230000003053 immunization Effects 0.000 description 5
- 238000002649 immunization Methods 0.000 description 5
- 239000002398 materia medica Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000010791 quenching Methods 0.000 description 5
- 230000000306 recurrent effect Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 239000002689 soil Substances 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 4
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 4
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 4
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 208000031971 Yin Deficiency Diseases 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 206010006451 bronchitis Diseases 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 4
- 229960001231 choline Drugs 0.000 description 4
- 229960004397 cyclophosphamide Drugs 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 208000001780 epistaxis Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 229930182470 glycoside Natural products 0.000 description 4
- 208000006454 hepatitis Diseases 0.000 description 4
- 231100000283 hepatitis Toxicity 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 206010022437 insomnia Diseases 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 4
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 4
- 235000014347 soups Nutrition 0.000 description 4
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 4
- 201000008827 tuberculosis Diseases 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 206010010741 Conjunctivitis Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 208000007882 Gastritis Diseases 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 229920001202 Inulin Polymers 0.000 description 3
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 240000001949 Taraxacum officinale Species 0.000 description 3
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 206010001093 acute tonsillitis Diseases 0.000 description 3
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 3
- 230000001142 anti-diarrhea Effects 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 239000002221 antipyretic Substances 0.000 description 3
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 3
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 3
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 3
- 201000001352 cholecystitis Diseases 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000035617 depilation Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 230000001605 fetal effect Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 3
- 229940029339 inulin Drugs 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 201000003265 lymphadenitis Diseases 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000019175 phylloquinone Nutrition 0.000 description 3
- 239000011772 phylloquinone Substances 0.000 description 3
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 3
- 229960001898 phytomenadione Drugs 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 238000010025 steaming Methods 0.000 description 3
- 208000004371 toothache Diseases 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 244000118350 Andrographis paniculata Species 0.000 description 2
- BOJKULTULYSRAS-OTESTREVSA-N Andrographolide Chemical compound C([C@H]1[C@]2(C)CC[C@@H](O)[C@]([C@H]2CCC1=C)(CO)C)\C=C1/[C@H](O)COC1=O BOJKULTULYSRAS-OTESTREVSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 206010012442 Dermatitis contact Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 206010016952 Food poisoning Diseases 0.000 description 2
- 208000019331 Foodborne disease Diseases 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 102100035695 Gamma-aminobutyric acid receptor-associated protein Human genes 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000037319 Hepatitis infectious Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 101001001372 Homo sapiens Gamma-aminobutyric acid receptor-associated protein Proteins 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 241000282376 Panthera tigris Species 0.000 description 2
- 241001662443 Phemeranthus parviflorus Species 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 206010043866 Tinea capitis Diseases 0.000 description 2
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 2
- SZCBXWMUOPQSOX-LOFNIBRQSA-N Violaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C12OC1(C)CC(O)CC2(C)C)C=CC=C(/C)C=CC34OC3(C)CC(O)CC4(C)C SZCBXWMUOPQSOX-LOFNIBRQSA-N 0.000 description 2
- 239000004213 Violaxanthin Substances 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 235000009392 Vitis Nutrition 0.000 description 2
- 241000219095 Vitis Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- ASLUCFFROXVMFL-UHFFFAOYSA-N andrographolide Natural products CC1(CO)C(O)CCC2(C)C(CC=C3/C(O)OCC3=O)C(=C)CCC12 ASLUCFFROXVMFL-UHFFFAOYSA-N 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- QUKGYYKBILRGFE-UHFFFAOYSA-N benzyl acetate Chemical compound CC(=O)OCC1=CC=CC=C1 QUKGYYKBILRGFE-UHFFFAOYSA-N 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000001989 choleretic effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 208000010247 contact dermatitis Diseases 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000002951 depilatory effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- XTLWNMXYCHABQH-UHFFFAOYSA-N germanicol Natural products CC1(C)CCC2(C)CCC3(C)C(CCC4(C)C5(C)CCC(O)C(C)(C)C5CCC34C)C2=C1 XTLWNMXYCHABQH-UHFFFAOYSA-N 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000037308 hair color Effects 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 208000005252 hepatitis A Diseases 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 210000004914 menses Anatomy 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 201000002266 mite infestation Diseases 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229960000292 pectin Drugs 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000004080 punching Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 2
- 229940032091 stigmasterol Drugs 0.000 description 2
- 235000016831 stigmasterol Nutrition 0.000 description 2
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 2
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 2
- 208000009189 tinea favosa Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 208000019206 urinary tract infection Diseases 0.000 description 2
- 235000019245 violaxanthin Nutrition 0.000 description 2
- SZCBXWMUOPQSOX-PSXNNQPNSA-N violaxanthin Chemical compound C(\[C@@]12[C@](O1)(C)C[C@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/[C@]1(C(C[C@@H](O)C2)(C)C)[C@]2(C)O1 SZCBXWMUOPQSOX-PSXNNQPNSA-N 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- UUTKICFRNVKFRG-WDSKDSINSA-N (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrolidinyl]methyl]-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSCN1C(=O)[C@H]1NC(=O)CC1 UUTKICFRNVKFRG-WDSKDSINSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 244000296912 Ageratum conyzoides Species 0.000 description 1
- 235000004405 Ageratum conyzoides Nutrition 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- 241000092665 Atractylodes macrocephala Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 238000011735 C3H mouse Methods 0.000 description 1
- 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 235000016535 Capraria biflora Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- IFYMEZNJCAQUME-APKWKYNESA-N Chrysanthemaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1OC2(C)CC(O)CC(C)(C)C2=C1)C=CC=C(/C)C=CC3=C(C)CC(O)CC3(C)C IFYMEZNJCAQUME-APKWKYNESA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000220284 Crassulaceae Species 0.000 description 1
- 244000013539 Cuscuta australis Species 0.000 description 1
- 241000110637 Cuscuta chinensis Species 0.000 description 1
- 241001609679 Cuscuta japonica Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000008265 Favism Diseases 0.000 description 1
- 239000004211 Flavoxanthin Substances 0.000 description 1
- JRHJXXLCNATYLS-NGZWBNMCSA-N Flavoxanthin Chemical compound C/C([C@H]1C=C2C(C)(C)C[C@H](O)C[C@@]2(C)O1)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C JRHJXXLCNATYLS-NGZWBNMCSA-N 0.000 description 1
- QHUMOJKEVAPSCY-JOJDNVQPSA-N Flavoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C1(C)OC2(C)CC(O)CC(C)(C)C2=C1)C=CC=C(/C)C=CC3C(=CC(O)CC3(C)C)C QHUMOJKEVAPSCY-JOJDNVQPSA-N 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- XJMPAUZQVRGFRE-SCHFUKFYSA-N Gardenoside Natural products O=C(OC)C=1[C@H]2[C@H]([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)[C@@](O)(CO)C=C2 XJMPAUZQVRGFRE-SCHFUKFYSA-N 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 description 1
- IBFYXTRXDNAPMM-FZEIBHLUSA-N Geniposide Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]2[C@@H]1CC=C2CO IBFYXTRXDNAPMM-FZEIBHLUSA-N 0.000 description 1
- 206010018444 Glucose-6-phosphate dehydrogenase deficiency Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 208000015924 Lithiasis Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- VLCHQFXSBHIBRV-KNNWKXJLSA-N Mussaenosidic acid Natural products O=C(O)C=1[C@@H]2[C@H]([C@H](O[C@@H]3[C@@H](O)[C@H](O)[C@H](O)[C@@H](CO)O3)OC=1)[C@](O)(C)CC2 VLCHQFXSBHIBRV-KNNWKXJLSA-N 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 241000117280 Naematelia aurantialba Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000013557 Plantaginaceae Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 101710202015 Protein 1.6 Proteins 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 241000405911 Rehmannia glutinosa Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 235000000661 Rosa laevigata Nutrition 0.000 description 1
- 241001278833 Rosa laevigata Species 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- YSIFYNVXJOGADM-KDYWOABDSA-N Shanzhiside Chemical compound O([C@H]1[C@H]2[C@@H](C(=CO1)C(O)=O)[C@H](O)C[C@@]2(O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YSIFYNVXJOGADM-KDYWOABDSA-N 0.000 description 1
- PVPIPGMAEAJMTH-UHFFFAOYSA-N Shanzhiside Natural products OCC1OC(OC2OC=C(C3C(O)CC(O)C23)C(=O)O)C(O)C(O)C1O PVPIPGMAEAJMTH-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 210000000662 T-lymphocyte subset Anatomy 0.000 description 1
- 235000015360 Taraxacum officinale ssp. ceratophorum Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 244000178320 Vaccaria pyramidata Species 0.000 description 1
- 235000010587 Vaccaria pyramidata Nutrition 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- VGLLGNISLBPZNL-RBUKDIBWSA-N arborescoside Natural products O=C(OC)C=1[C@@H]2C([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)=C(CO)CC2 VGLLGNISLBPZNL-RBUKDIBWSA-N 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 229940007550 benzyl acetate Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000019243 flavoxanthin Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000001983 lactogenic effect Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- XJMPAUZQVRGFRE-AYDWLWLASA-N methyl (1s,4as,7s,7as)-7-hydroxy-7-(hydroxymethyl)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,7a-dihydro-1h-cyclopenta[c]pyran-4-carboxylate Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1[C@](C=C2)(O)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XJMPAUZQVRGFRE-AYDWLWLASA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 208000020615 rectal carcinoma Diseases 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 229960001005 tuberculin Drugs 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Abstract
The invention discloses a kind of Herba Taraxaci oral liquor improving immunity, including: the extraction of a. Herba Taraxaci, as component 1;B. remaining crude drug described is put into heating and refluxing extraction 2 times in ethanol, as component 2;C. by 2-in-1 also to above two extracting solution component 1 and component, add Mel after concentration or dextrin is in harmonious proportion, after disinfection, be prepared as oral liquid bottling.In described step c, by 2-in-1 to component 1 and component and after, insert in economic benefits and social benefits vacuum concentrator, when being concentrated into 90 DEG C, relative density is the concentrated solution of 1.36, sets to 0~5 DEG C of deepfreezes 24 hours;The filter aid kieselguhr adding 0.3% by cold preservation liquid, filters.The present invention is not difficult to the taste of Chinese medicine swallowed, and makes people be prone to accept, and can improve sub-health population easy catching a cold with long-term taking, eyes are sour and astringent, sleep quality is the highest, insufficiency of the spleen weak;Lack of appetite xerostomia;Deficiency of the kidney soreness of the waist and knees;Nocturia, impotence and seminal emission;The symptoms such as tinnitus mesh is dark.
Description
Technical field
The present invention relates to, containing the medical health product deriving from plant, animal or raw mineral materials, improve particularly to one
Herba Taraxaci oral liquid of immunity and preparation method thereof.
Background technology
Human immunity is the defensive enginery of human body pathogenic microorganism etc. to external world, or perhaps system of defense, normally
In the case of, it ensure that human body is not encroached on by extraneous pathogenic microorganism.The body immunity generally said refers to human body
Immune system resists the ability of the infringements such as exotic disease pathogenic microorganism.In the case of body immunity is normal, human body self can
Resist the infringement of considerable pathogenic bacteria, it is to avoid human body is caused damage.Immunity plays important work in human life mechanism
With, and the nutrition of human body, fatigue, mood, environment, disease, medication, radiation etc. cause the immunity degradation of self.Millions of years
Coming, the mankind are at one environment being not only suitable for existence but also being fraught with risks of life, and the mankind are able to survival, also obtain outstanding immunity
Power.Immunity is the product of biological evolution process thus.
The health of hypoimmunity is prone to infected or cancer stricken;Immunity is extraordinary also can produce insalubrious knot
Really, as caused anaphylaxis, autoimmune disease etc..A variety of causes makes immune system can not normally play protective effect, at this
In the case of, easily cause antibacterial, virus, fungus etc. and infect, therefore hypoimmunity the most directly shows is exactly liable to illness.Cause
The most ill, increased the weight of the consumption of body, so typically have a delicate constitution, malnutrition, lethargy, fatigue and weak, appetite
Reduction, sleep disorder etc. show, sick, having an injection to take medicine has become homely food.The most sick will being lot more time to is recovered,
And usually recurrent exerbation.Health and intelligent development if things go on like this can be caused bad, the most easily induce major disease.Underlying causes is
Hypoimmunity or immunity are unsound.When immune function of human body is lacked of proper care, or when immune system is unsound, following point will
Recurrent exerbation:--flu recurrent exerbation, tonsillitis recurrent exerbation, asthma recurrent exerbation, bronchitis recurrent exerbation, pneumonia are anti-
Recurrence is made, diarrhoea recurrent exerbation ... so necessarily can't neglect.
Immunity refers to that body resists external invasion and attack, safeguards the ability of homoiostasis.Air is filled with various
The microorganism of various kinds: antibacterial, virus, mycoplasma, chlamydia, fungus etc..In the case of body immunity is low, they are all
The pathogen of sense mornig shift can be become.Although human body can produce corresponding antibody to different pathogen, to resist subinfection again,
But antibody has specificity and time-bounded, such as streptococcus antibody can only protect in short period of time body not by streptococcic again
Secondary infringement, also can not resist the infection of other viruses.The people of hypoimmunity cannot resist the invasion and attack of cold virus at all, this
It is only the true cause that Susceptible population frequently catches a cold.
Dandelion herb, rich in vitamin A, vitamin C and potassium, also contains ferrum, calcium, vitamin B2, vitamin B1, magnesium, dimension life
Element B6, folic acid and copper.Concrete constituent content is mainly moisture, every 60 grams of dandelion herb leaf moisture contents 86%, protein 1.6
Gram, carbohydrate 5.3 grams, heat there are about 108.8 kilojoules.Containing taraxol, taraxacin, gallbladder in Herba Taraxaci plant
The multiple health-nutrition compositions such as alkali, organic acid, inulin.Nature and flavor are sweet, micro-hardship, cold.Return liver, stomach warp.Have diuresis, cathartic, jaundice eliminating subcutaneous ulcer,
The effects such as function of gallbladder promoting.Control pyretic toxicity, carbuncle, skin infection, abscess of internal organ, conjunctival congestion and swelling pain, damp and hot, the puckery pain of jaundice, dribbling urination, furuncle swelling toxin, breast
Carbuncle, scrofula, toothache, conjunctival congestion, pharyngalgia, lung abscess, acute appendicitis, jaundice due to damp-heat, the puckery pain of pyretic stranguria.Control acute mastitis, lymphadenitis, scrofula
Scrofula, furuncle carbuncle toxin, acute conjunctivitis, cold, fever, acute tonsillitis, acute bronchitis, gastritis, hepatitis, cholecystitis, urine
Road feel dye etc..Herba Taraxaci is raw-eaten, stir-fry and eat, cook soup, is the plant of dietotherapeutic.
Herba Taraxaci improves immunity, diuresis eliminating stagnation.Control acute mastitis, lymphadenitis, scrofula, furuncle carbuncle toxin, acute knot
Film is scorching, cold, fever, acute tonsillitis, acute bronchitis, gastritis, hepatitis, cholecystitis, urinary tract infection.Tang Materia Medica: main
Married woman's acute mastitis swells." Bencao Tujing ": apply skin ulcer, controls again evil thorn and contact dermatitis." Amplification on Materia Medica addendum ": heat-transformation poison, the swollen tuberculosis of the evil that disappears,
Detoxicating food-poisoning, dissipates stagnant gas." the southern regions of the Yunnan Province book on Chinese herbal medicine ": apply all pyogenic infections from tumour or sore, mange tinea skin ulcer;Dispeling the wind, disappear all sores, dissipates scrofula tuberculosis;Only urine
Blood, controls the five types of stranguria difficulty in urination, profit bladder." detailed outline ": crow beard and hair, strengthening bone and muscle." Bencao Jingshu ": Herba Taraxaci is hidden sweet flat, and its property is nontoxic.When
It is to enter stomach, the key medicine of antipyretic removing heat from blood into liver.Acute mastitis belongs to Liver Channel, and married woman is after row, and Liver Channel is taken charge, therefore housewife's human milk carbuncle breast is malicious,
And preferably give birth to warm good." book on Chinese herbal medicine is stated ": Herba Taraxaci, bitter more than Gan Erwei, it is Gan Ping and has the person of being slightly cold concurrently also.Uncommon harmony is said: sweet flat it
The bright Liver and kidney of agent point.' hide this language, then know its enter stomach and double enter Liver and kidney, not so, how removing heat from blood, crow beard and hair, to appoint it together in punching
Blood is dirty?I.e. think of, then east wall what is called kidney channel must user, especially when in the same way, improper only before cured mainly use up also." this
Grass is newly organized ": Herba Taraxaci, to the low-pricedest and have big merit, do not know to use it by means of common people.The fire that sun is bright, often to setting a prairie fire, with Baihu Tang with pathogenic fire purging,
Injure one's stomach gas rather.Fire in lid stomach is contained, owing to stomach sergeant declines also, pathogenic fire purging and soil more declines.Therefore with tiger soup certainly, to rush down stomach-fire, be
A period of time extremely suitable, and can not rely on for prolonged also.Herba Taraxaci also rushes down the medicine of stomach-fire, but its gas is the most flat, can pathogenic fire purging, do not damage
Soil, can grow clothes clothes for a long time and not hinder.Fire the person that all systems sun is bright, all agent greatly can take it, and fire moves back and gastric qi is spontaneous.But its pathogenic fire purging it
Power is little, it is necessary to multiplex, and one or two, few also five, six money, begin to dissipate evil auxiliary positive ear.Or ask, Herba Taraxaci pathogenic fire purging, the fire that antidiarrheal sun is bright,
Fail to see the fire of each warp, also can disappear to the greatest extent?Say, the strongest person of fire, without crossing the bright flame of sun, the fire fall that sun is bright, and each through ember without
Disappear not to the utmost.Though the medicine of the non-each warp of Herba Taraxaci, and the fire of each warp, see Herba Taraxaci and most volt, i.e. call Herba Taraxaci and can disappear the fire of each warp, also
Can not be also.Or ask, Herba Taraxaci and Flos Lonicerae, it is both the thing of eliminating carbuncle infections, two things who victory after all?Husband's Herba Taraxaci stop into sun bright,
Lunar two warps, Flos Lonicerae is not then without through entering, and Herba Taraxaci can not be same as function also with Flos Lonicerae.So Flos Lonicerae obtains Herba Taraxaci and it
Merit is bigger.
Herba Taraxaci herb contains taraxasterol, choline, inulin, pectin etc..In root containing taraxol, taraxerol, ψ-
Portugal's Herba Taraxaci sterol, taraxasterol, β-Amyrin, stigmasterol, cupreol, choline, organic acid, fructose, sucrose, Fructus Vitis viniferae
Sugar, glycoside and resin, rubber etc..Leaf containing phylloxanthin, violaxanthin, phylloquinone, vitamin C (50~70 milligrams/
100 grams) and vitamin D (5~9 milligrams/100 grams).
Containing arnica montana glycol, phylloxanthin and flavoxanthin in spending.In pollen containing cupreol, 5z-bean steroid-7-alkene-3 β-
Alcohol, folic acid and vitamin C.Containing phylloquinone in green calyx.Containing cupreol and β-Amyrin in scape.These product are advanced in years containing examining again
This torr alcohol, the micro-gram gram of riboflavin 1.43 and carotene 7.7~8.8 milligrams of %.
(1) antibacterial action: in this product injection test tube, staphylococcus aureus resistance bacterial strain, Hemolytic streptococcus are had relatively
Strong bactericidal action.To Diplococcus pneumoniae, meningococcus, diphtheria corynebacterium, bacillus pyocyaneus, dysentery bacterium, Bacillus typhi etc. and
Micrococcus catarrhalis also has certain bactericidal action.This product alcohol extract 1: 400 can suppress tulase, but decoct 1: 100 is invalid.It is 1: 80 years old
Water decoction can delay ECHO11 viral cytopathic, ethanol extract (31mg/kg) can kill leptospira, also have some fungus
Inhibitory action.Campylobacter pylori is had good killing action.
(2) lactogenesis: this product leaf has the obstruction of dredging breast vascular, promotes the effect of lactogenic.
(3) antitumor action: the polysaccharide (Tof mono-CFr) extracted in common dandelion, with 40,2,600mg/kg ip awards
The C3H mouse of inoculation MM46 tumor cell, early stage is administered the effect that has no, but is administered the next day of the later stage of 11~20 days and 2~20 days
The most effective.Tumor cell is delayed type anaphylaxis (T mono-DHR), at ddy mono-Ehrlich (same tumor) is and C3H mono-
During MM46 (syngeneic tumor) is, the Tof mono-CFr later stage is administered its footpad reaction and the most substantially rises compared with matched group.In ADMC system
In, Tof mono-CFr, compared with the glycogen being known to activated macrophage, has higher activation capability
(4) choleretic effect: foreign study, these product have choleretic effect, clinical treatment chronic gallbladder spasmolytic and calculosis to have
Effect.The effects such as this product still has diuresis stomach invigorating in addition, hypocatharsis.
Being three points of poison of medicine, Chinese medicine health care product must control dosage well so that it is toxicity is preferably minimized.The present invention greatly improves
Chinese medicine extraction technology so that the toxic component of Chinese medicine is preferably minimized, can make absorption of human body, is greatly improved its utilization rate.Control
Dosage;Strengthen " dose-effect relationship " and " amount poison relation " research;Use modern technologies, inside and outside method combining assessment.
Summary of the invention
The technical problem to be solved is, the technical problem to be solved is, modern exempts from
Epidemic disease power is just becoming more and more fragile, environmental pollution, work and rest irregular, rhythm of life fast, eat unhealthy, do not know controlling desire, cause
The sickness rate of various diseases is all constantly rising.Family of the most so-called office, the especially group of people at high risk of hypoimmunity.Greatly
Groups of people are sub-health states, in overdraw originally with regard to unsound health.The symptom of most people is insomnia and dreamful sleep, susceptible
Emit, eyes are sour and astringent, insufficiency of the spleen weak;Lack of appetite xerostomia;Quench one's thirst;Deficiency of the kidney soreness of the waist and knees;Impotence and seminal emission;Tinnitus mesh is dark;Early whitening of beard and hair;Body
Empty win is thin;Wind favus disease.How to find safely and effectively active substance health product, immunity, health invigorating one can be greatly improved
It is directly people's keys of expecting solution problem.The present invention greatly improves Chinese medicine extraction technology so that the toxic component of Chinese medicine drops to
Minimum, absorption of human body can be made, be greatly improved its utilization rate.
For solving above-mentioned technical problem, the present invention provides a kind of Herba Taraxaci oral liquid improving immunity, and it is described oral
Liquid can include the crude drug of following parts by weight: Herba Taraxaci 10~50 parts, Herba Artemisiae Scopariae 10~20 parts, Spica Prunellae 10~20 parts, chrysanthemum
Spend 10~20 parts, the Radix Paeoniae Alba 10~20 parts, the Rhizoma Atractylodis Macrocephalae 10~20 parts, Herba Sedi 10~20 parts, Rhizoma Curcumae 10~20 parts, Fructus Schisandrae Chinensis 10~20
Part, Fructus Rosae Laevigatae 10~20 parts, Cortex Lycii 10~20 parts, Radix Salviae Miltiorrhizae 10~20 parts, Herba Ecliptae 10~20 parts, Radix Polygoni Multiflori Preparata 10~20 parts,
Semen Cuscutae 10~20 parts, Fructus Gardeniae 10~20 parts, Radix Rehmanniae Preparata 10~20 parts, Herba Andrographis 10~20 parts.
The Herba Taraxaci oral liquid of described raising immunity, in its described oral liquid, the parts by weight of various crude drug can also
For: Herba Taraxaci 10~30 parts, Herba Artemisiae Scopariae 10~15 parts, Spica Prunellae 10~15 parts, Flos Chrysanthemi 10~15 parts, the Radix Paeoniae Alba 10~15 parts, the Rhizoma Atractylodis Macrocephalae
10~15 parts, Herba Sedi 10~15 parts, Rhizoma Curcumae 10~15 parts, Fructus Schisandrae Chinensis 10~15 parts, Fructus Rosae Laevigatae 10~15 parts, Cortex Lycii 10~
20 parts, Radix Salviae Miltiorrhizae 10~20 parts, Herba Ecliptae 10~20 parts, Radix Polygoni Multiflori Preparata 10~20 parts, Semen Cuscutae 10~20 parts, Fructus Gardeniae 10~20 parts,
Radix Rehmanniae Preparata 10~20 parts, Herba Andrographis 10~20 parts.
The Herba Taraxaci oral liquid of described raising immunity, in its described oral liquid, the parts by weight of various crude drug are all right
For: Herba Taraxaci 10~40 parts, Herba Artemisiae Scopariae 10~20 parts, Spica Prunellae 10~20 parts, Flos Chrysanthemi 10~20 parts, the Radix Paeoniae Alba 10~20 parts, the Rhizoma Atractylodis Macrocephalae
10~20 parts, Herba Sedi 10~20 parts, Rhizoma Curcumae 10~20 parts, Fructus Schisandrae Chinensis 10~20 parts, Fructus Rosae Laevigatae 10~20 parts, Cortex Lycii 10~
15 parts, Radix Salviae Miltiorrhizae 10~15 parts, Herba Ecliptae 10~15 parts, Radix Polygoni Multiflori Preparata 10~15 parts, Semen Cuscutae 10~15 parts, Fructus Gardeniae 10~15 parts,
Radix Rehmanniae Preparata 10~15 parts, Herba Andrographis 10~15 parts.
For solving above-mentioned technical problem, the present invention also provides for the preparation side of a kind of Herba Taraxaci oral liquid improving immunity
Method, the preparation process of its described oral liquid includes:
A. the extraction of Herba Taraxaci, as component 1;
B. remaining crude drug described is put into heating and refluxing extraction 2 times in ethanol, as component 2;
C. by 2-in-1 also to above two extracting solution component 1 and component, add Mel after concentration or dextrin is in harmonious proportion, after disinfection
It is prepared as oral liquid bottling.
In described step a, can shred after plucking Herba Taraxaci, be soaked and be placed in lid stainless steel cask, add 70%
Ethanol, quality is coarse grained 0.8-1 times, stirs, moistening airtight placement more than 1 hour, makes fully to expand;By percolation
Bottom Tong filter plate gauze bag parcel pave after again the drug sample after moistening expansion is mixed pine do dissipate, then with rustless steel spoon contain
Powder, loads percolator uniformly, fills 10-12 cm thick, even by T-bar pressure, then presses aforesaid operations, and loading in layer is suitable
Working as pressurization, medicated powder loads 2/3 eminence that must not exceed percolator;Medicated powder face upper cover rustless steel orifice plate fastens, and opens under percolator
The baiting valve in face, and put a container, then it is slowly added into 70% ethanol;Air between medicated powder powder to be discharged, and have second
Alcohol flows out about about 20L, closes baiting valve, covers cylinder of filtering, dipping 24 hours, then opens baiting valve and carries out percolation, controls percolation
Speed is generally 1000g medical material outflow per minute 2~3ml, and filtrate puts into liquid container, and pours ethanol during emptying into storage
Fluid cylinder;Being merged by percolate and stand, stand for standby use, as component 1.
In described step b, remaining raw material described can be steeped and account in its quality 10 times amount ethanol, heating extraction 2 times, often
Secondary 1-2 hour, taking supernatant, united extraction liquid, 100-120 mesh filters, then the ultrafiltration that molecular weight is 5000-10000 through damming
Post ultrafiltration, the extractum of 1.06 when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C, heat and be concentrated into paste, stand for standby use, in groups
Divide 2.
In described step c, can by 2-in-1 to component 1 and component and after, insert in economic benefits and social benefits vacuum concentrator, be concentrated into 90 DEG C
Time relative density be the concentrated solution of 1.36, set to 0~5 DEG C of deepfreezes 24 hours;The filter aid diatom that cold preservation liquid is added 0.3%
Soil, filters, and filtrate is inserted in economic benefits and social benefits vacuum concentrator again, is concentrated into every 1ml crude drug amount Han 0.1g;Unguentum after concentration adds Mel
Or dextrin is in harmonious proportion, bottle after ultraviolet ray sterilization bactericidal.
For solving above-mentioned technical problem, the present invention also provides for the preparation side of a kind of Herba Taraxaci oral liquid improving immunity
Method, its preparation process can also be:
A. Herba Taraxaci is added ethanol extraction, as component 1;
B. after being extracted by Herba Taraxaci, residue is soaked together with remaining crude drug described, is extracted 2 times as component 2;
C. add Mel after component 1, component 2 being mixed concentration to be in harmonious proportion, bottle after ultraviolet ray sterilization bactericidal.
In described step a, the Herba Taraxaci plucked can be cleaned, put into extraction pot after dry in the sun and add and account for its quality 5-10 times
Amount ethanol, heating extraction 2 times, each 1-2 hour, take supernatant, united extraction liquid, 100-120 mesh filters, then through the molecule that dams
Amount is the ultrafiltration post ultrafiltration of 5000-10000, and the extractum of 1.06 when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C, as component
1;In described step b, the Herba Taraxaci dregs of extraction are put into together with remaining raw material described and accounts in its quality 5-10 times amount water, leaching
Steeping 1-2 hour, heating extraction 2 times, each 1-2 hour, take supernatant, united extraction liquid, 100-120 mesh filters, and extracts 2 times
Liquid merges standing, and reducing pressure and being concentrated into liquor strength is 0.6g crude drug/mL, after sucking filtration, when the relative density of filtrate is about 20 DEG C
1.08;Being decompressed to 0.03-0.08MPa, temperature is maintained at 60-80 DEG C, and being concentrated into relative density is 1.20, temperature to 60 DEG C-70
DEG C extractum, as component 2.
In described step c, after component 1 can be mixed, put into concentrating under reduced pressure tank with component 2, decompression recycling ethanol is dense
Being reduced to liquor strength is 0.1g crude drug/mL, when the relative density of sucking filtration to filtrate is 20 DEG C 1.06;Above-mentioned filtrate through volume is
After the macroporous adsorptive resins absorption of 10L, with deionized water or the distilled water eluting of 10 times of resin column volumes, then with 5 times of resins
95% ethanol elution of column volume, collects ethanol elution, removes solvent, then is in harmonious proportion Mel, bottles after ultraviolet ray sterilization bactericidal.
Medical verification, Herba Taraxaci can improve immunity, hypoglycemic, has antiobesity action, clears up the intestines and stomach, and toxin expelling is supported
Face, liver nourishing lung moistening, the present invention is a kind of to have antibacterial, the Chinese medicine health care product of antivirus action, especially exhales in flu, pharyngitis etc.
Inhale road infection and there is obvious therapeutical effect.There is effect of heat-clearing and toxic substances removing, anti-inflammatory analgetic, resisiting influenza virus, be to prevent and control
Treat influenza, pharyngolaryngitis, all diseases of pyretic toxicity, the optimal natural drug of acute gastroenteritis.Do not have unpleasant to be difficult to swallow
Flavour of a drug, make people be prone to accept, and can preferably improve sub-health population easy catching a cold with long-term taking, eyes are sour and astringent, sleep quality
The highest, insufficiency of the spleen weak;Lack of appetite xerostomia;Quench one's thirst;Deficiency of the kidney soreness of the waist and knees;Impotence and seminal emission;Tinnitus mesh is dark;Early whitening of beard and hair;Body void is won thin;
The symptom of wind favus disease, can preferably reach to improve effect of immunity.
Detailed description of the invention
Human immunity is the defensive enginery of human body pathogenic microorganism etc. to external world, or perhaps system of defense, normally
In the case of, it ensure that human body is not encroached on by extraneous pathogenic microorganism.The body immunity generally said refers to human body
Immune system resists the ability of the infringements such as exotic disease pathogenic microorganism.In the case of body immunity is normal, human body self can
Resist the infringement of considerable pathogenic bacteria, it is to avoid human body is caused damage.Immunity plays important work in human life mechanism
With, and the nutrition of human body, fatigue, mood, environment, disease, medication, radiation etc. cause the immunity degradation of self.More and more
Research shows, the regulation of body immunity is increasingly played a significant role by Chinese medicine.
Herba Taraxaci improves immunity, diuresis eliminating stagnation.Control acute mastitis, lymphadenitis, scrofula, furuncle carbuncle toxin, acute knot
Film is scorching, cold, fever, acute tonsillitis, acute bronchitis, gastritis, hepatitis, cholecystitis, urinary tract infection.Tang Materia Medica: main
Married woman's acute mastitis swells." Bencao Tujing ": apply skin ulcer, controls again evil thorn and contact dermatitis." Amplification on Materia Medica addendum ": heat-transformation poison, the swollen tuberculosis of the evil that disappears,
Detoxicating food-poisoning, dissipates stagnant gas." the southern regions of the Yunnan Province book on Chinese herbal medicine ": apply all pyogenic infections from tumour or sore, mange tinea skin ulcer;Dispeling the wind, disappear all sores, dissipates scrofula tuberculosis;Only urine
Blood, controls the five types of stranguria difficulty in urination, profit bladder." detailed outline ": crow beard and hair, strengthening bone and muscle." Bencao Jingshu ": Herba Taraxaci is hidden sweet flat, and its property is nontoxic.When
It is to enter stomach, the key medicine of antipyretic removing heat from blood into liver.Acute mastitis belongs to Liver Channel, and married woman is after row, and Liver Channel is taken charge, therefore housewife's human milk carbuncle breast is malicious,
And preferably give birth to warm good." book on Chinese herbal medicine is stated ": Herba Taraxaci, bitter more than Gan Erwei, it is Gan Ping and has the person of being slightly cold concurrently also.Uncommon harmony is said: sweet flat it
The bright Liver and kidney of agent point.' hide this language, then know its enter stomach and double enter Liver and kidney, not so, how removing heat from blood, crow beard and hair, to appoint it together in punching
Blood is dirty?I.e. think of, then east wall what is called kidney channel must user, especially when in the same way, improper only before cured mainly use up also." this
Grass is newly organized ": Herba Taraxaci, to the low-pricedest and have big merit, do not know to use it by means of common people.The fire that sun is bright, often to setting a prairie fire, with Baihu Tang with pathogenic fire purging,
Injure one's stomach gas rather.Fire in lid stomach is contained, owing to stomach sergeant declines also, pathogenic fire purging and soil more declines.Therefore with tiger soup certainly, to rush down stomach-fire, be
A period of time extremely suitable, and can not rely on for prolonged also.Herba Taraxaci also rushes down the medicine of stomach-fire, but its gas is the most flat, can pathogenic fire purging, do not damage
Soil, can grow clothes clothes for a long time and not hinder.Fire the person that all systems sun is bright, all agent greatly can take it, and fire moves back and gastric qi is spontaneous.But its pathogenic fire purging it
Power is little, it is necessary to multiplex, and one or two, few also five, six money, begin to dissipate evil auxiliary positive ear.Or ask, Herba Taraxaci pathogenic fire purging, the fire that antidiarrheal sun is bright,
Fail to see the fire of each warp, also can disappear to the greatest extent?Say, the strongest person of fire, without crossing the bright flame of sun, the fire fall that sun is bright, and each through ember without
Disappear not to the utmost.Though the medicine of the non-each warp of Herba Taraxaci, and the fire of each warp, see Herba Taraxaci and most volt, i.e. call Herba Taraxaci and can disappear the fire of each warp, also
Can not be also.Or ask, Herba Taraxaci and Flos Lonicerae, it is both the thing of eliminating carbuncle infections, two things who victory after all?Husband's Herba Taraxaci stop into sun bright,
Lunar two warps, Flos Lonicerae is not then without through entering, and Herba Taraxaci can not be same as function also with Flos Lonicerae.So Flos Lonicerae obtains Herba Taraxaci and it
Merit is bigger.
Herba Taraxaci herb contains taraxasterol, choline, inulin, pectin etc..In root containing taraxol, taraxerol, ψ-
Portugal's Herba Taraxaci sterol, taraxasterol, β-Amyrin, stigmasterol, cupreol, choline, organic acid, fructose, sucrose, Fructus Vitis viniferae
Sugar, glycoside and resin, rubber etc..Leaf containing phylloxanthin, violaxanthin, phylloquinone, vitamin C (50~70 milligrams/
100 grams) and vitamin D (5~9 milligrams/100 grams).
Spica Prunellae has the effect of improving eyesight of relieving inflammation or internal heat, and can control conjunctival congestion and swelling pain, headache etc..This product decoct, water-leach liquor, alcohol-water
Leachate and alcohol leaching liquid all can obviously reduce laboratory animal blood pressure, and stem, leaf, fringe and herb all have a hypotensive effect, but fringe
Act on more apparent;This product water decoction-alcohol sedimentation liquid mouse peritoneal is injected, and has obvious antiinflammatory action;This product decoct is in vitro to dysentery bar
Bacterium, Bacillus typhi, vibrio cholera, escherichia coli, Bacillus proteus, staphylococcus and Bacillus tuberculosis all have certain suppression to make
With.Spica Prunellae compatibility Radix Angelicae Sinensis, Radix Paeoniae Alba Spica Prunellae liver heat removing scattered silt;Radix Angelicae Sinensis, the Radix Paeoniae Alba nourish blood and enrich blood. and three 5 is with having solution stagnation of liver-QI, nourishing the liver
Effect of blood is used for treating all diseases caused by hepatic depression and blood deficiency. Spica Prunellae compatibility Flos Chrysanthemi Spica Prunellae clearing away liver-fire, suppressing the hyperactive liver sun;Flos Chrysanthemi heat clearing away is cool
Liver. Papillary have liver heat removing, cool liver, suppressing the hyperactive liver merit for treating flaming up of liver-fire, wind-heat of liver channel causes conjunctival congestion and swelling pain;Or on liver-yang
High cause headache, dizziness.
The Radix Paeoniae Alba is bitter, is slightly cold.Return Liver Channel.Attending effectiveness: clearing away heat and cooling blood;Blood circulation promoting and blood stasis dispelling.Main maculae caused by violent heat pathogen;Hematemesis and epistaxis;Intestinal
Wind hematochezia;Conjunctival congestion and swelling pain;Carbuncle skin infection;Amenorrhea;Dysmenorrhea;Metrorrhagia and leukorrhagia stranguria with turbid discharge;The stagnant hypochondriac pain of the stasis of blood;Hernia abdominal mass is gathered;Injury from falling down.For temperature
Poison sends out speckle, hematemesis and epistaxis, conjunctival congestion and swelling pain, hypochondriac pain due to stagnation of liverQI, amenorrhea dysmenorrhea, lump in the abdomen stomachache, injury from falling down, carbuncle skin infection." herbal classic ":
Main pathogen is suffered from abdominal pain, and except arthralgia due to stagnation of blood, broken heavily fortified point is long-pending, cold and heat hernia abdominal mass, pain relieving, diuresis, QI invigorating." not Lu ": clear and coherent blood vessels, slow in, dissipate and dislike
Blood, expelling extravasated blood, go aqueous vapor, profit bladder intestine and small intestine, subduing inflammation, time row cold and heat, attacked by pestiferous factors suffers from abdominal pain, lumbago." property of medicine opinion ": control pathogen of the lung
Gas, abdominal pain pain, vim and vigour are gathered, and lead to a surname's internal organs and gather around gas, control evil pain deteriorated blood, and time main, disease bone heat, strong the five internal organs, the kidney invigorating gas, control trusted subordinate
Hard swollen, married woman's blood closes obstructed, repercussive blood, can lose pus.
Herba Ecliptae Compositae, annual herb plant.Uprightly, tool stolon;Leaf is to life, lanceolar;Head inflorescence, axil raw or
Top is raw, floral white;Achene black.Whole nation dispersed species.It is common in field stalk, Gou Xi limit wetland.Herb is medicinal, can restrain, stops blooding, mend
Effect of Liver and kidney.The diseases such as nourishing the liver and kidney, cooling blood for hemostasis, can control various haematemesis, enterorrhagia.Smash juice painting eyebrow to send out, can promote that hair is raw
Long, for oral administration have black hair, hair color effect.Tang Materia Medica is said, Herba Ecliptae " main dysentery, acupuncture skin ulcer sends out, flood blood can not the person of stopping respect it " " day
China's son book on Chinese herbal medicine " in also say, Herba Ecliptae can " evacuation of pus, hemostasis, logical small intestinal, apply all skin ulcers silkworm ".
Radix Polygoni Multiflori have Radix Polygoni Multiflori and Radix Polygoni Multiflori Preparata point, direct slicing is used as medicine for Radix Polygoni Multiflori, dries after mixing steaming with Semen sojae atricolor liquor
It is used as medicine for Radix Polygoni Multiflori Preparata.The function of the two is different: the removing toxic substances of Radix Polygoni Multiflori function, eliminating carbuncle, loosening bowel to relieve constipation, is usually used in treating scrofula skin ulcer
Carbuncle, rubella pruritus, dryness of the intestine constipation;Radix Polygoni Multiflori Preparata function invigorating the liver and kidney, benefiting essence-blood, crow beard and hair, bone and muscle strengthening, for blood deficiency and yellow complexion, dizziness
Tinnitus, early whitening of beard and hair, soreness of the waist and knees, numb limbs and tense tendons, bleeding not during menses, chronic malaria body void etc..Radix Polygoni Multiflori Preparata of the present invention is to mend
The good merchantable brand of kidney kidney tonifying.
Fructus Gardeniae bitter cold, can blood system and clear pathogen is warm, wide intestinal relieving constipation, anti-cancer, Flos Gardeniae contains cellulose, can prevent hemorrhoid
Make and the generation of rectum carcinoma.Radix Gardeniae, leaf, fruit all can be used as medicine, and have pathogenic fire purging relieving restlessness, and antiinflammatory is dispelled heat, clearing away heat and promoting diuresis, external
Effect of removing toxic substances.Flos Gardeniae, fruit, leaf and Gen Ke are used as medicine, and typically make tea or decoct soup clothes.Fructus Gardeniae containing gardenoside, geniposide,
Herba Paederiae time glycoside methyl ester and a small amount of shanzhiside, have that clearing away heat and promoting diuresis, external removing toxic substances, jaundice, stranguria with blood pain be the most puckery, the red and swollen pain of mesh, fire-toxin skin ulcer,
The effects such as blood pressure lowering.Wherein fruit of Fructus Gardeniae is used as medicine, and cures mainly calentura hyperpyrexia, dysphoria and insomnia, and excess-fire is had a toothache, aphtha of the mouth and tongue, and nose is advised, told
Blood, eye conjunctivitis, sore swollen toxin, icteric infectious hepatitis, favism, hematuria;Traumatic hemorrhage, bruise are controlled in external.Root enters
Medicine cures mainly infectious hepatitis, traumatic injury, acute toothache.Compendium of Material Medica claims it, and " improving healthy complexion, it is used by " a thousand pieces of gold wing " face cream.”
" the southern regions of the Yunnan Province book on Chinese herbal medicine " claims its " purte the white, only cough due to lung-heat, only epistaxis blood, expectorant." meridian distribution of property and flavor: cold in nature, sweet-bitter flavor;Enter lung, liver
Warp.Effect: clearing away lung-heat to relieve cough, external is stopped blooding.Cure mainly cough due to lung-heat, nose, cough up phlegm, the disease such as toxic swelling.Main component: Flos Gardeniae
Containing Triterpenoid, Fructus Gardeniae flower acid A, B and son acid.Containing volatile oil, including benzyl acetate, linalyl acetate, another containing pigment glycoside, wood
Honey alcohol etc..It addition, possibly together with carbohydrate, protein, crude fibre and multivitamin.
Fructus Rosae Laevigatae, Chinese medicine name.Dry mature fruit for rosaceous plant Fructus Rosae Laevigatae Rosa laevigata Michx..
It is distributed in Shaanxi, Anhui, Jiangxi, Jiangsu, Zhejiang, Hubei, Hunan, Guangdong, Guangxi, Taiwan, Fujian, Sichuan, Yunnan, Guizhou etc.
Ground.There is controlling nocturnal emission with astringent drugs reducing urination, stopping metrorrhagia and leukorrhagia, effect of relieving diarrhea with astringents.It is usually used in emission and spermatorrhea, enuresis frequent micturition, bleeding not during menses, chronic diarrhea
Chronic dysentery.
Fructus Schisandrae Chinensis is magnoliaceae schisandra Schisandra chinensis (Turcz.) Baill. or Central China five tastes
The dry mature fruit of sub-Schisandra sphenanthera Rehd.et Wils..The former practises title " Radix Schisandrae Bicoloris ", the latter
Practise and claim " Fructus Schisandrae Sphenantherae ".Pluck during fruit maturation in autumn, dry after drying or steaming, remove carpopodium and impurity." the Xin Xiuben such as Tang
Grass " carry " the sweet acid of five tastes skin and flesh, arduous in core, have saline taste ", therefore have the name of Fructus Schisandrae Chinensis.Fructus Schisandrae Chinensis is divided into two kinds of south, north.Ancient doctor
Book claim it, profound and, meeting and, be listed in the top grade Chinese medicine in Sheng Nong's herbal classic the earliest, can the power of strengthening by means of tonics, medical value is high,
There is the effect of building body, share treatment insomnia with fine jade treasure Ganoderma.
Herba Artemisiae Scopariae clearing away heat-damp and promoting diuresis;Jaundice eliminating.Cure mainly: jaundice, dysuria, eczema pruritus, infectious jaundice type hepatitis.Deng. medicine
Pharmacological research has function of gallbladder promoting, liver function protecting, and antipyretic, antiinflammatory, blood fat reducing, blood pressure lowering, coronary dilating etc. acts on. Herba Artemisiae Scopariae and Herba Artemisiae Annuae, both
Fragrant odour, can solve damp and hot, therefore jaundice due to damp-heat, hygropyrexia, the card of fever disease in summer, all can apply.But Herba Artemisiae Scopariae master enters taste, for jaundice eliminating master
Medicine;Herba Artemisiae Annuae master enters liver, gallbladder, and merit specially solves hectic fever due to YIN-deficiency consumptive fever, especially can let out the fire of fever disease in summer, for hectic fever due to YIN-deficiency consumptive fever, malaria cold and heat and fever disease in summer high fever
Commonly used.
Effect of Flos Chrysanthemi and effect: taste is micro-pungent, sweet, bitter, cold nature.Energy dispelling wind and heat pathogens, liver heat removing and eyesight improving, suppressing the hyperactive liver sun, removing toxic substances.
For cold anemopyretic, heating giddy;Liver Channel has heat;The many tear of conjunctival congestion, or the hepatic and renal YIN deficiency, eyes is dim-sighted;Excessive rising of liver-YANG, dizziness head
Bitterly;Skin infection swells and ache.Modern times are again for coronary heart disease, hypertension.Blood pressure lowering: Flos Chrysanthemi has blood pressure lowering, eliminates cancerous cell, expansion hat
Shape tremulous pulse and antibacterial effect, long-term drink can increase human body calcareous, regulation myocardial function, reduce cholesterol, be suitable for person in middle and old age
Drink when people and prevention epidemic conjunctivitis.
Cortex Lycii heat clearing away, removing heat from blood.Control asthenia hectic fever night sweat, lung-heat cough with asthma, spit blood, epistaxis, stranguria with blood, quench one's thirst, hypertension, carbuncle
Swollen, malignant boil." herbal classic ": " pathogen in main five, hankers quenching one's thirst, general arthralgia." " not Lu ": " main air is wet, and lower breast side of body gas, exopathogenic heat is had a headache, and mends
Internal injury great Lao is hissed suction, hard muscle, reinforcing YIN-essence, profit intestine and small intestine, resistance to cold and summer-heat.″
The Rhizoma Atractylodis Macrocephalae, Classification system Atractylodes macrocephala.Another name small wooden raft Ji, Rhizoma Atractylodis Macrocephalae, the winter Rhizoma Atractylodis Macrocephalae, wash rice art, poplar
Small wooden raft, Wu Shu, sheet art, Rhizoma Atractylodis etc., belong to Compositae, [WTBX herbaceos perennial.The nice and cool weather of happiness, is used as medicine with rhizome, has
Multinomial medicinal function.It is distributed mainly on the mountain area wetlands such as Sichuan, Yunnan, Guizhou.The Rhizoma Atractylodis Macrocephalae has invigorating the spleen and benefiting QI, dampness diuretic, stops
Antiperspirant, antiabortive effect, for insufficiency of the spleen lack of appetite, abdominal distention is had loose bowels, phlegm retention vertigo and palpitation, edema, spontaneous perspiration, frequent fetal movement." medicine origin " is remembered
Carry: " dehumidifying benefit is dry, and middle QI invigorating, warming middle-JIAO, go in taste wet, except gastric heat, strong taste, enter diet, antiabortive.”
Semen Cuscutae Cuscuta chinensis is dicotyledon scammonia section plant Semen Cuscutae, Cuscuta australis, cuscuta japonica Choisy etc.
Seed, can the kidney invigorating and essence nourishing, nourishing the liver to improve visual acuity, effect of solid tire stopping leak.Nourishing the liver and kidney, controlling nocturnal emission with astringent drugs reducing urination, antiabortive, improving eyesight, antidiarrheal.For
Impotence and seminal emission, dripping urination, enuresis frequent micturition, soreness of the waist and knees, blurred vision tinnitus, vaginal bleeding due to deficiency of the kidney during pregnancy, frequent fetal movement, spleen kidney vaginal bleeding during pregnancy, fetal movement
Uneasy, spleen is suffered from a deficiency of the kidney and is rushed down;Externally treating leucoderma.Former medicine sieve is removed spare, picks decontamination, dry
Radix Rehmanniae Preparata is the tuber of scrophulariaceae rehmannia glutinosa plant (formal name used at school: Rehmannia glutinosa), has another name called Radix Rehmanniae Preparata or volt
Ground, the processed process of preparing Chinese medicine forms.Generally with wine, Fructus Amomi, Pericarpium Citri Reticulatae for adjuvant through repeatedly steaming solarization, glossy to inside and outside darkish complexion, quality is soft
Sticky.Section use, or parch to black use.Radix Rehmanniae Preparata has another name called Radix Rehmanniae Preparata or throws oneself on the ground, and belongs to goatweed, is a kind of first-class Chinese crude drug, has
YIN nourishing of enriching blood effect, can be used for blood deficiency and yellow complexion, dizziness, palpitation and insomnia, menoxenia, the disease such as metrorrhagia, also can be used for deficiency of kidney yin
Hectic fever hectic fever due to YIN-deficiency, night sweat, pass out semen, the disease such as quench one's thirst, be one of deficiency syndrome class nonprescription drugs medicine LIUWEI DIHUANG WAN main component.
Herba Sedi, Chinese medicine name.Dry herb for crassulaceae plants Herba Sedi.Sweet, light, cool.There are dampness removing jaundice eliminating, heat clearing away solution
Effect of poison.It is usually used in jaundice due to damp-heat, dysuria, carbuncle skin infection.Return liver, gallbladder, small intestine meridian.Effect dampness removing jaundice eliminating, heat clearing away solution
Poison.Cure mainly for jaundice due to damp-heat, dysuria, carbuncle skin infection.
Herba Andrographis (formal name used at school: Andrographis paniculata (Burm.f.) Nees), has another name called Chun Lianqiuliu, sees
Happiness, Lan Helian, Radix Gentianae, gold Rhizoma et radix valerianae, Tremella aurantialba Bandoni et Zang hook, India's grass, Herba vallisneriae Spiralis etc..Annual herb plant, long 4~8 centimetres, wide 1~
2.5 centimetre.Medicinal plants, has heat-clearing and toxic substances removing, antiinflammatory, reducing swelling and alleviating pain effect.Herba Andrographis water decoction can improve peripheral blood in vitro
The ability of leukocytes phagocytic staphylococcus aureus.Have been reported that oral Herba Andrographis can make tumour patient and other patient or Healthy People
Skin delayed-type allergy caused by old tuberculin is strengthened.Dexyandrographolide injection also can strengthen phagocytic function.
3H--thymidine penetrates into the in vitro tests of lymphocyte and shows, PHA is promoted by Herba Andrographis soluble derivative injection
3H--thymus pyrimidine is infiltrated with inhibitory action.Dehydroandrograpolide succinate (DAS) with andrographolide synthesis is right
2,4--trinitro-chlorobenzene induced mice delayed hypersensitivity also has inhibitory action.Andrographolide has and substantially suppresses venous blood
The effect of middle carbon powder Cl.Creat formulation one Xin get Ping (including ester and ketone) can improve mice serum Lysozyme Levels.
The specific embodiment of the invention
Specific embodiment 1:
Pluck new fresh Herba Taraxaci 5000g, clean and soaked after dry in the sun in ethanol 1-2 hour, heating extraction 2 times, every time
1-2 hour, taking supernatant, united extraction liquid, 100-120 mesh filters, then the ultrafiltration post that molecular weight is 5000-10000 through damming
Ultrafiltration, the extractum of 1.06 when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C, heating is concentrated into paste, stand for standby use, becomes component
1。
By remaining crude drug Herba Artemisiae Scopariae 1000g, Spica Prunellae 1000g, Flos Chrysanthemi 1000g, Radix Paeoniae Alba 1000g, Rhizoma Atractylodis Macrocephalae 1000g, hang down basin
Grass 1000g, Rhizoma Curcumae 1000g, Fructus Schisandrae Chinensis 1000g, Fructus Rosae Laevigatae 1000g, Cortex Lycii 1000g, Radix Salviae Miltiorrhizae 1000g, Herba Ecliptae 1000g,
Radix Polygoni Multiflori Preparata 1000g, Semen Cuscutae 1000g, Fructus Gardeniae 1000g, Radix Rehmanniae Preparata 1000g, Herba Andrographis 1000g, put in weight 10 times amount ethanol,
Soak 1-2 hour, heating extraction 2 times, each 1-2 hour, united extraction liquid, after standing, take supernatant, be then placed in reducing pressure dense
In contracting tank, decompression recycling ethanol, being concentrated into liquor strength is 0.6g crude drug/mL, when the relative density of sucking filtration to filtrate is 80 DEG C
The extractum of 1.06, becomes component 2.
By 2-in-1 to component 1 and component and after insert in economic benefits and social benefits vacuum concentrator, when being concentrated into 90 DEG C, relative density is 1.36
Concentrated solution, sets to 0~5 DEG C of deepfreezes 24 hours;The filter aid kieselguhr adding 0.3% by cold preservation liquid, filters, and filtrate is inserted double again
In effect vacuum concentrator, it is concentrated into every 1ml crude drug amount Han 0.1g;Unguentum after concentration adds dextrin and is in harmonious proportion, ultraviolet ray sterilization bactericidal
Rear bottling.
Specific embodiment 2:
Plucking new fresh Herba Taraxaci, clean dry in the sun, 5000g, is soaked and has been placed in lid stainless steel cask, added 70% ethanol altogether
Liquid, quality is coarse grained 0.8-1 times, stirs, moistening airtight placement more than 1 hour, makes fully to expand;At the bottom of percolator
Drug sample after moistening expansion is mixed pine after paving and is done to dissipate by portion's filter plate gauze bag parcel again, then contains powder with rustless steel spoon,
Load percolator uniformly, fill 10-12 cm thick, even by T-bar pressure, then press aforesaid operations, and loading in layer, suitably add
Pressure, medicated powder loads 2/3 eminence that must not exceed percolator;Medicated powder face upper cover rustless steel orifice plate fastens, and opens below percolator
Baiting valve, and put a container, then it is slowly added into 70% ethanol;Air between medicated powder powder to be discharged, and have ethanol stream
Go out about about 20L, close baiting valve, cover cylinder of filtering, dipping 24 hours, then open baiting valve and carry out percolation, control percolation speed
Generally 1000g medical material outflow per minute 2~3ml, filtrate is put into liquid container, and is poured ethanol during emptying into reservoir
Cylinder;Being merged by percolate and stand, stand for standby use, as component 1.
By Herba Artemisiae Scopariae 1200g, Spica Prunellae 1200g, Flos Chrysanthemi 1100g, Radix Paeoniae Alba 1200g, Rhizoma Atractylodis Macrocephalae 1200g, Herba Sedi 1100g, cowherb
Art 1100g, Fructus Schisandrae Chinensis 1200g, Fructus Rosae Laevigatae 1200g, Cortex Lycii 1200g, Radix Salviae Miltiorrhizae 1100g, Herba Ecliptae 1100g, Radix Polygoni Multiflori Preparata
1200g, Semen Cuscutae 1200g, Fructus Gardeniae 1200g, Radix Rehmanniae Preparata 1200g, Herba Andrographis 1200g, put into 10 times amount by the medicine of remaining crude drug
In ethanol, soak 1-2 hour, heating extraction 2 times, each 1-2 hour, united extraction liquid, take supernatant after standing, be then placed in
In concentrating under reduced pressure tank, decompression recycling ethanol, being concentrated into liquor strength is 0.6g crude drug/mL, and the relative density of sucking filtration to filtrate is
The extractum of 1.06 when 20 DEG C, becomes component 2.
By 2-in-1 to component 1 and component and after insert in economic benefits and social benefits vacuum concentrator, when being concentrated into 90 DEG C, relative density is 1.35
Concentrated solution, sets to 0~5 DEG C of deepfreezes 24 hours;The filter aid kieselguhr adding 0.3% by cold preservation liquid, filters, and filtrate is inserted double again
In effect vacuum concentrator, it is concentrated into every 1ml crude drug amount Han 0.1g;Unguentum after concentration adds dextrin and is in harmonious proportion, ultraviolet ray sterilization bactericidal
Rear bottling.
Specific embodiment 3: pluck new fresh Herba Taraxaci, cleans dry in the sun, altogether after 4500g, puts into extraction pot heating extraction 2 times,
1-2 hour every time, taking supernatant, united extraction liquid, 100-120 mesh filters, then through the molecular weight that dams be the super of 5000-10000
Filter post ultrafiltration, the extractum of 1.06 when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C, as component 1, by remaining raw material mattress described
Old 1200g, Spica Prunellae 1200g, Flos Chrysanthemi 1100g, Radix Paeoniae Alba 1200g, Rhizoma Atractylodis Macrocephalae 1200g, Herba Sedi 1100g, Rhizoma Curcumae 1100g, the five tastes
Sub-1200g, Fructus Rosae Laevigatae 1200g, Cortex Lycii 1200g, Radix Salviae Miltiorrhizae 1100g, Herba Ecliptae 1100g, Radix Polygoni Multiflori Preparata 1200g, Semen Cuscutae
1200g, Fructus Gardeniae 1200g, Radix Rehmanniae Preparata 1200g, Herba Andrographis 1200g, put in weight 5-10 times amount water, soak 1-2 hour, and heating carries
Taking 2 times, each 1-2 hour, take supernatant, united extraction liquid, 100-120 mesh filters, and is merged by 2 extracting solution and stands, decompression
Reclaim ethanol, and to be concentrated into liquor strength be 0.6g crude drug/mL, after sucking filtration, when the relative density of filtrate is about 20 DEG C 1.08;Subtract
Being depressed into 0.03-0.08MPa, temperature is maintained at 60-80 DEG C, and being concentrated into relative density is 1.20, the leaching of temperature to 60 DEG C-70 DEG C
Cream, as component 2.The mixing of component 1 component 2 being inserted in economic benefits and social benefits vacuum concentrator, when being concentrated into 90 DEG C, relative density is 1.05
Concentrated solution, set to 0~5 DEG C of deepfreezes 24 hours;The filter aid kieselguhr adding 0.3% by cold preservation liquid, filters, and filtrate is inserted again
In economic benefits and social benefits vacuum concentrator, it is concentrated into every 1ml crude drug amount Han 0.1g;Unguentum after concentration, bottles after ultraviolet ray sterilization bactericidal.
Specific embodiment 4: pluck new fresh Herba Taraxaci, cleans dry in the sun, altogether after 4500g, steeps in 10 times amount ethanol, and heating carries
Taking 2 times, each 1-2 hour, take supernatant, united extraction liquid, 100-120 mesh filters, then through the molecular weight that dams be 5000-
The ultrafiltration post ultrafiltration of 10000, the extractum of 1.06 when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C, heating is concentrated into paste, quiet
Purchase use, become component 1.By Herba Artemisiae Scopariae 1200g, Spica Prunellae 1200g, Flos Chrysanthemi 1100g, Radix Paeoniae Alba 1200g, Rhizoma Atractylodis Macrocephalae 1200g, Herba Sedi
1100g, Rhizoma Curcumae 1100g, Fructus Schisandrae Chinensis 1200g, Fructus Rosae Laevigatae 1200g, Cortex Lycii 1200g, Radix Salviae Miltiorrhizae 1100g, Herba Ecliptae 1100g, system
Radix Polygoni Multiflori 1200g, Semen Cuscutae 1200g, Fructus Gardeniae 1200g, Radix Rehmanniae Preparata 1200g, Herba Andrographis 1200g, put into pulverizer by described crude drug
After pulverizing, particulate matter is put into heating and refluxing extraction 2 times in ethanol, each 1~2 hour, 2 extracting solution is merged and stands;Will
The medicinal residues that above-mentioned ethanol extraction is crossed add 10 times amount water heating and refluxing extraction 2 times, each 1~2 hour, merge quiet by 2 extracting solution
Put, above two extracting solution is merged, as component 2;Merge component 1 component 2 concentrating under reduced pressure relative density when being 80 DEG C 1.36
Filtrate, reclaim ethanol, call in propolis, after ultraviolet sterilization bottle.
Pharmacological toxicity is tested
One, skin irritation test
1, experimental technique
Depilatory is uniformly coated with by guinea pig back spinal column both sides, makes unhairing scope about 20 square centimeters.Clean depilatory
Returning cage to observe 24 hours, often group Cavia porcellus is coated with the present invention 4,8 and 12g respectively, 92mg, 184mg and 368mg Han crude drug respectively, another
Group is coated with the every twice-daily of solvent 0.8ml, continuous one week, after experiment terminates, is put to death by Cavia porcellus, the heart, liver, and kidney and depilation skin do pathology
Inspection.
2, result
Above-mentioned three groups of medication Cavia porcellus trunks depilation district, has no that local skin has edema, hyperemia, erythema, petechia and ulcer.
Medication group Cavia porcellus chroma of hair, ingest, the matched group no significant difference such as extremity are movable, histopathologic examination, the administration group heart,
Liver, kidney and depilation skin compare also no significant difference with compareing word.
Result is pointed out, and the present invention, without local irritant effect, also has no that general toxicity shows.Show that invention formulation uses peace
Entirely.
Two, animal acute toxicity test research:
The present invention is through trial test, it is impossible to measures LD 50, therefore measures maximum dosage-feeding.Use rectal delivery, record little
The maximum dosage-feeding on the one of Mus is 62.7g/kg (in terms of medicated powder), and about (people is with 60kg for 1567.5 times of the clinical people's consumption of plan
Meter), the maximum dosage-feeding 62.7g/kg (in terms of medicated powder) on the one of rat, it is about intend clinical people's consumption 1567.5 times.Experiment is dynamic
The equal Continuous Observation of thing one week, its outward appearance sign, the mental status, diet, drinking-water, feces etc. are showed no obvious abnormalities.Experiment terminates
Time, all healthy survival of animal, body weight increases.
Three, long-term toxicity test for animals research:
This test sets medicine of the present invention high, medium and low dosage group and Matrix controls group, blank group, uses rectally
Approach gives rat, and dosage is respectively 3.2,2.4 and 1.6g/kg (in terms of medicated powder), is equivalent to intend clinical patient consumption
80,60 and 40 times of [0.04g (medicated powder)/kg], successive administration 2 months, in administration process, each administration group and matrix group rat
Body weight, dietary amount, outward appearance sign, behavioral activity, the mental status, hair color, feces character compare with blank group, without substantially
Not notable (the P > of difference (P > 0.05), the weight of animals increasing value and Main Organ Coefficients and blank group comparing difference
0.05), hematology and blood parameters check notable (the P < of the result indivedual index of administration group and blank group comparing difference
0.05), but convalescent period terminates rear discrepant hematology and blood parameters has recovered normal the most, and other indexs are right with blank
Not notable (P > 0.05) according to comparing difference, it is administered phase and convalescent period histological examination high dose group animal main organs with blank
Matched group compares and has no notable difference, has no that slowness toxicity occurs.
Pharmacodynamic experiment:
Using Immunology Today theory and technology, Study of Traditional Chinese Medicine is to strengthening and the effect of regulation body's immunity, and this is to explaining
The bright material base about theory of Chinese medical science has highly important meaning.The present invention by Herba Taraxaci, Radix Polygoni Multiflori Preparata, Herba Sedi etc. several
Natural drug forms through scientific compatibility.Existing research finds, the function of Herba Taraxaci adjustable body each system internal organs, to immunity
Cell and immune molecule all have regulation effect.This experiment is further intended to inquire into the present invention and regulates hypoimmunity mouse immune
The molecular immunology mechanism of effect.
1 materials and methods
1.1 instruments and reagent: Herba Taraxaci health care oral liquid of the present invention is provided (preparing by embodiment 2 method) by the court;Note
Penetrate and provided by Hualian Pharmaceutical Co., Ltd., Shanghai with cyclophosphamide.Cytokine detection kits is all purchased from R&D company of the U.S..Stream
Formula cell instrument, 2000FCA, U.S. company BD production.
1.2 animal Kunming system male mices 30, in 5-7 week, body weight is 25 ± 2g, by the limited duty of Shandong University's laboratory animal
Ren company provides.
1.3 method
1.3.1 Kunming system male mice is randomly divided into 3 groups with packet by Animal Model: blank group, model group
With medicine group, often group 10.Blank group: in experiment process, any process is not made in normal raising;Model group: intraperitoneal injection
100mg/kg cyclophosphamide causes hypoimmunity model, 1 time/d, for three days on end;Medicine group: intraperitoneal injection 100mg/kg ring
Phosphamide causes hypoimmunity model, 1 time/d, for three days on end, and within first day, smears administration at the left tibialis anterior of mice in modeling,
Only, booster immunization 1 time after a week, dosage is with for the first time for 0.1mL/.Collecting sample after 4d.
1.3.2, after the mensuration mice of mouse immune shoot formation weighs in, cervical dislocation puts to death mice, takes thymus, spleen
Its weight in wet base of dirty title, calculating thymus index and spleen index: thymus index=chest gland weight × 1000/ body weight spleen index=spleen weight ×
1000/ body weight 1.3.3 mice serum IgG, the mensuration of IgM level presses test kit description method, measures IgG in mice serum,
IgM content.
1.3.4 mouse boosting tissue T lymphocyte and subgroup CD4+ thereof, the mensuration of CD8+ and CD4+/CD8+ is aseptic takes spleen, puts
In filling in right amount without, in Hank ' s liquid plate, being ground by spleen gently with tweezers, make single born of the same parents' suspension, filter through 200 eye mesh screens,
By cell suspension in the complete culture solution of 1mL, adjust cell concentration 1 × 109L-1, with micropipettor carefully by 100 μ L
The fully splenocyte suspension of mixing is added to the bottom of sample feeding pipe, adds 20 μ L monoclonal antibodies, low-speed oscillation mixing 3S, room temperature lucifuge
Hatch 30min, after The medicine studyPREP broken red blood cell, flow cytometer detection T cell subgroup content.
1.3.5 the mensuration of mice serum IFN-Y, IL-10 level presses test kit description method, measure IFN-Y in serum,
The level of IL-10.
The 1.2 all numerical value of statistical procedures all represent with x ± s, use SPSS13.0 statistical software to carry out data analysis, group
Between compare employing t inspection.Using P < 0.05 as statistical significant difference standard.
2 results
The impact of hypoimmunity mouse immune organ is drawn by 2.1 by table 1, compared with Normal group, and model group spleen
Dirty and thymus index significantly reduces, and difference is statistically significant, P < 0.01.Compare with model group, medicine group mouse spleen index
Substantially increasing, have statistical significance, P < 0.01, thymus index also increased, but difference is the most notable.
Table 1 present invention on hypoimmunity mouse immune organ weight impact (n=10, mean ± s)
Group | Index and spleen index (mg/g) | Thymus index (mg/g) |
Normal group | 6.06±1.04 | 3.23±1.01 |
Model group | 2.91±0.89ΔΔ | 1.45±0.75ΔΔ |
Of the present invention group | 5.33 ± 0.42** | 1.92±0.86 |
Compare with Normal group: △: P < 0.05, Δ Δ: P < 0.01;Compare with model group: *: P < 0.05, * *: P <
0.01
The impact of hypoimmunity mouse boosting tissue T lymph subgroup is found out by 2.2 by table 2, compared with Normal group, and mould
Type group mouse spleen CD4+ cell subsets percentage drop, CD8+ cell subsets percentage ratio rises, has significant difference, P <
0.05, CD4+/CD8+ ratio substantially reduces, and has pole significant difference, P < 0.01.And medicine group can substantially offset ring phosphinylidyne
Amine destroys the effect of immunity, has significant difference, P < 0.05.
Table 2 Buddha's warrior attendant sky shield liquid on hypoimmunity mice body fluid T cell subgroup impact (n=10, mean ± SD)
Compare with Normal group: Δ P < 0.05, Δ Δ P < 0.05;With than model group: * P < 0.05, * * P < 0.05.
Thymus, spleen are the important lymphatic organ of body.Thymus is that T cell is grown, differentiation, ripe place, its structure
And function is closely related with fuselage state.The reduction of thymus index and atrophy of thymus gland, be all that mice is based on cellular immunization
Immunosuppressant shows.Spleen is the peripheral immune organ of internal maximum, and the immunocyte of spleen is based on bone-marrow-derived lymphocyte, and B
Lymphocyte is the main cell participating in humoral immunization, and therefore spleen and humoral immunity of organism is in close relations.Thymus index and
Spleen index has reacted the power of immune body function intuitively.This experiment shows, the present invention is low to caused by cyclophosphamide immunity
The growth of lower mouse spleen has facilitation, and the growth to thymus also has certain facilitation.T lymphocyte can by its function
It is divided into two subgroups of CD4+ and CD8+.CD4+T lymphocyte is in very important Central Position in the immunoreation of body,
It is by secretion other T of multiple Lymphokine, B cell subgroup and participate in other cells immunoreactive so that it is propagation and
Differentiation, and coordinate the interaction between immunocyte, play the function of body immune system.The ratio of CD4+/CD8+ rises, and carries
Show that the just regulation of immunne response is preponderated, and ratio declines, point out immunologic hypofunction.T lymphocyte subset group in human peripheral blood
Mensuration, show that the present invention can make the percentage composition of caused by cyclophosphamide hypoimmunity mice CD4+T lymphocyte raise,
The ratio making CD4+/CD8+ rises, and T lymphocyte immunity system is played positive control by the prompting present invention.IgG, IgM level is then
Reflect humoral immunization ability.The study show that the present invention promotes that hypoimmunity mouse IgG, IgM secrete increase.This is described
The bright enhancing not only promoting Immune Function, also has facilitation simultaneously to humoral immunization.
Claims (10)
1. the preparation method of the Herba Taraxaci oral liquid improving immunity, it is characterised in that preparation process includes:
A. the extraction of Herba Taraxaci, as component 1;
B. remaining crude drug described is put into heating and refluxing extraction 2 times in ethanol, as component 2;
C. by 2-in-1 also to above two extracting solution component 1 and component, add Mel after concentration or dextrin is in harmonious proportion, prepare after disinfection
Become oral liquid bottling.
Improve the preparation method of the Herba Taraxaci oral liquid of immunity the most according to claim 1, it is characterised in that described step
In a, shredding, soaked and be placed in lid stainless steel cask, add 70% ethanol after plucking Herba Taraxaci, quality is coarse grained
0.8-1 times, stir, moistening airtight placement more than 1 hour, make fully to expand;By the gauze bag bag of filter plate bottom percolator
Wrap up in again the drug sample after moistening expansion is mixed after paving pine do dissipate, then with rustless steel spoon contain powder, load percolator uniformly,
Dress 10-12 cm thick, even by T-bar pressure, then press aforesaid operations, loading in layer, suitably pressurize, medicated powder must not load and surpassed
Cross 2/3 eminence of percolator;Medicated powder face upper cover rustless steel orifice plate fastens, and opens the baiting valve below percolator, and puts a container,
Then 70% ethanol it is slowly added into;Air between medicated powder powder to be discharged, and have ethanol to flow out about about 20L, closedown is put
Material valve, covers cylinder of filtering, dipping 24 hours, then opens baiting valve and carries out percolation, controls percolation speed and is generally 1000g medical material every point
Clock flows out 2~3ml, and filtrate puts into liquid container, and pours ethanol during emptying into liquid container;Percolate is merged and stands,
Stand for standby use, as component 1.
Improve the preparation method of the Herba Taraxaci oral liquid of immunity the most according to claim 1, it is characterised in that described step
In b, remaining raw material described is steeped and accounts in its quality 10 times amount ethanol, heating extraction 2 times, each 1-2 hour, take supernatant,
United extraction liquid, 100-120 mesh filters, then the ultrafiltration post ultrafiltration that molecular weight is 5000-10000 through damming, and ultrafiltrate decompression is dense
The extractum of 1.06 when contracting relative density is 80 DEG C, heating is concentrated into paste, stand for standby use, becomes component 2.
Improve the preparation method of the Herba Taraxaci oral liquid of immunity the most according to claim 1, it is characterised in that described step
In c, by 2-in-1 to component 1 and component and after, insert in economic benefits and social benefits vacuum concentrator, when being concentrated into 90 DEG C relative density be 1.36 dense
Contracting liquid, sets to 0~5 DEG C of deepfreezes 24 hours;The filter aid kieselguhr adding 0.3% by cold preservation liquid, filters, and filtrate inserts economic benefits and social benefits again
In vacuum concentrator, it is concentrated into every 1ml crude drug amount Han 0.1g;Unguentum after concentration adds Mel or dextrin is in harmonious proportion, disinfection by ultraviolet light
Bottle after sterilization.
5. the preparation method of the Herba Taraxaci oral liquid improving immunity, it is characterised in that preparation process is:
A. Herba Taraxaci is added ethanol extraction, as component 1;
B. after being extracted by Herba Taraxaci, residue is soaked together with remaining crude drug described, is extracted 2 times as component 2;
C. add Mel after component 1, component 2 being mixed concentration to be in harmonious proportion, bottle after ultraviolet ray sterilization bactericidal.
Improve the preparation method of the Herba Taraxaci oral liquid of immunity the most according to claim 5, it is characterised in that described step
In a, the Herba Taraxaci plucked is cleaned, put into extraction pot after dry in the sun and add and account for its quality 5-10 times amount ethanol, heating extraction 2 times,
1-2 hour every time, taking supernatant, united extraction liquid, 100-120 mesh filters, then through the molecular weight that dams be the super of 5000-10000
Filter post ultrafiltration, the extractum of 1.06 when ultrafiltrate concentrating under reduced pressure relative density is 80 DEG C, as component 1;In described step b, will carry
The Herba Taraxaci dregs taken are put into together with remaining raw material described and are accounted in its quality 5-10 times amount water, soak 1-2 hour, heating extraction
2 times, each 1-2 hour, taking supernatant, united extraction liquid, 100-120 mesh filters, and is merged by 2 extracting solution and stands, and decompression is also
Being concentrated into liquor strength is 0.6g crude drug/mL, after sucking filtration, when the relative density of filtrate is about 20 DEG C 1.08;It is decompressed to 0.03-
0.08MPa, temperature is maintained at 60-80 DEG C, and being concentrated into relative density is 1.20, and the extractum of temperature to 60 DEG C-70 DEG C, as component
2。
Improve the preparation method of the Herba Taraxaci oral liquid of immunity the most according to claim 5, it is characterised in that described step
In c, putting into concentrating under reduced pressure tank, decompression recycling ethanol with component 2 after component 1 being mixed, being concentrated into liquor strength is that 0.1g is raw
Medicine/mL, when the relative density of sucking filtration to filtrate is 20 DEG C 1.06;Above-mentioned filtrate is inhaled through the macroporous adsorptive resins that volume is 10L
Attached, with deionized water or the distilled water eluting of 10 times of resin column volumes, then with 95% ethanol elution of 5 times of resin column volumes,
Collect ethanol elution, remove solvent, then be in harmonious proportion Mel, bottle after ultraviolet ray sterilization bactericidal.
8. the Herba Taraxaci oral liquid improving immunity, it is characterised in that include the crude drug of following parts by weight: Herba Taraxaci
10~50 parts, Herba Artemisiae Scopariae 10~20 parts, Spica Prunellae 10~20 parts, Flos Chrysanthemi 10~20 parts, the Radix Paeoniae Alba 10~20 parts, the Rhizoma Atractylodis Macrocephalae 10~20 parts,
Herba Sedi 10~20 parts, Rhizoma Curcumae 10~20 parts, Fructus Schisandrae Chinensis 10~20 parts, Fructus Rosae Laevigatae 10~20 parts, Cortex Lycii 10~20 parts, Radix Salviae Miltiorrhizae
10~20 parts, Herba Ecliptae 10~20 parts, Radix Polygoni Multiflori Preparata 10~20 parts, Semen Cuscutae 10~20 parts, Fructus Gardeniae 10~20 parts, Radix Rehmanniae Preparata 10~20
Part, Herba Andrographis 10~20 parts.
Improve the Herba Taraxaci oral liquid of immunity the most according to claim 8, it is characterised in that include following parts by weight
Crude drug: Herba Taraxaci 10~30 parts, Herba Artemisiae Scopariae 10~15 parts, Spica Prunellae 10~15 parts, Flos Chrysanthemi 10~15 parts, the Radix Paeoniae Alba 10~15 parts,
The Rhizoma Atractylodis Macrocephalae 10~15 parts, Herba Sedi 10~15 parts, Rhizoma Curcumae 10~15 parts, Fructus Schisandrae Chinensis 10~15 parts, Fructus Rosae Laevigatae 10~15 parts, Cortex Lycii
10~20 parts, Radix Salviae Miltiorrhizae 10~20 parts, Herba Ecliptae 10~20 parts, Radix Polygoni Multiflori Preparata 10~20 parts, Semen Cuscutae 10~20 parts, Fructus Gardeniae 10~20
Part, Radix Rehmanniae Preparata 10~20 parts, Herba Andrographis 10~20 parts.
Improve the Herba Taraxaci oral liquid of immunity the most according to claim 8, it is characterised in that include following parts by weight
Crude drug: Herba Taraxaci 10~40 parts, Herba Artemisiae Scopariae 10~20 parts, Spica Prunellae 10~20 parts, Flos Chrysanthemi 10~20 parts, the Radix Paeoniae Alba 10~20
Part, the Rhizoma Atractylodis Macrocephalae 10~20 parts, Herba Sedi 10~20 parts, Rhizoma Curcumae 10~20 parts, Fructus Schisandrae Chinensis 10~20 parts, Fructus Rosae Laevigatae 10~20 parts, ground
Cortex Lycii 10~15 parts, Radix Salviae Miltiorrhizae 10~15 parts, Herba Ecliptae 10~15 parts, Radix Polygoni Multiflori Preparata 10~15 parts, Semen Cuscutae 10~15 parts, Fructus Gardeniae 10
~15 parts, Radix Rehmanniae Preparata 10~15 parts, Herba Andrographis 10~15 parts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610626472.7A CN106237234A (en) | 2016-08-02 | 2016-08-02 | Improve Herba Taraxaci oral liquor and the oral liquid thereof of immunity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610626472.7A CN106237234A (en) | 2016-08-02 | 2016-08-02 | Improve Herba Taraxaci oral liquor and the oral liquid thereof of immunity |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106237234A true CN106237234A (en) | 2016-12-21 |
Family
ID=57606422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610626472.7A Pending CN106237234A (en) | 2016-08-02 | 2016-08-02 | Improve Herba Taraxaci oral liquor and the oral liquid thereof of immunity |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106237234A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103734426A (en) * | 2013-12-31 | 2014-04-23 | 青岛恒波仪器有限公司 | Health-care cornus officinalis tea capable of improving immunity and preparation method of tea |
CN105343625A (en) * | 2015-12-04 | 2016-02-24 | 青岛安倍康生物医药技术有限公司 | Taraxacum oral liquid for expelling toxin, dehumidifying and benefiting gallbladder and preparation method thereof |
-
2016
- 2016-08-02 CN CN201610626472.7A patent/CN106237234A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103734426A (en) * | 2013-12-31 | 2014-04-23 | 青岛恒波仪器有限公司 | Health-care cornus officinalis tea capable of improving immunity and preparation method of tea |
CN105343625A (en) * | 2015-12-04 | 2016-02-24 | 青岛安倍康生物医药技术有限公司 | Taraxacum oral liquid for expelling toxin, dehumidifying and benefiting gallbladder and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102145064B (en) | Traditional Chinese medicine composition for treating senile vaginitis and preparation method thereof | |
CN103734428B (en) | A kind of glossy privet fruit health-care tea improving immunity and preparation method thereof | |
CN105343625A (en) | Taraxacum oral liquid for expelling toxin, dehumidifying and benefiting gallbladder and preparation method thereof | |
CN102784363B (en) | Traditional Chinese medicine composition for treating pancreatic cancer and preparation method thereof | |
CN104305205B (en) | A kind of Semen Cuscutae oral liquid improving immunity and preparation method thereof | |
CN102988675B (en) | Traditional Chinese medicine combination for treating chronic prostatitis and preparation method thereof | |
CN103041262B (en) | Traditional Chinese medicine enema for curing chronic prostatitis and preparing method thereof | |
CN105194421A (en) | Self-heal health-care oral solution capable of reducing blood fat and preparation method thereof | |
CN106237131A (en) | The Herba Taraxaci oral liquor of lowering blood-fat and reducing weight and oral liquid thereof | |
CN106214997A (en) | A kind of Herba Taraxaci oral liquid of Elmination of toxicant and fat-lowering fat-reducing and preparation method thereof | |
CN106177540A (en) | A kind of Herba Taraxaci oral liquid of clearing away heat to alleviate pain and preparation method thereof | |
CN105169278A (en) | Dandelion oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof | |
CN106110204A (en) | A kind of Herba Taraxaci oral liquid improving immunity and preparation method thereof | |
CN105233056A (en) | Rhubarb oral liquid capable of clearing away heat and removing dampness and beneficial to choleresis and detoxification and preparation method of rhubarb oral liquid | |
CN105166237A (en) | Salvia miltiorrhiza leaf health tea capable of protecting and nourishing liver and preparation method thereof | |
CN105343516A (en) | Selfheal oral liquid for treating liver-fire flaming and preparation method of oral liquid | |
CN103860948A (en) | Traditional Chinese medicine for treating acute mastitis caused by qi stagnation and heat congestion and preparation method thereof | |
CN105998448A (en) | Method for preparing mulberry oral solution for improving immunity and oral solution prepared by same | |
CN106237234A (en) | Improve Herba Taraxaci oral liquor and the oral liquid thereof of immunity | |
CN106266672A (en) | A kind of Semen Cuscutae health care oral liquid of slow down aging and preparation method thereof | |
CN106237128A (en) | The Semen Cuscutae oral liquor of slow down aging and oral liquid thereof | |
CN106109916A (en) | A kind of Fructus Rosae Laevigatae health care oral liquid of slow down aging and preparation method thereof | |
CN105169277A (en) | Fructus gardeniae oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof | |
CN105998979A (en) | Traditional Chinese medicine composition for treating lung-and-kidney-yin-deficiency-type chronic pharyngitis and method | |
CN105169275A (en) | Rheum officinale oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161221 |